I was amused – oh, I should be polite and say “interested” -- to see a new study, led by researchers from Yale School of Public Medicine, about the benefits of a universal single payor health system. It concluded that we could save 100,000 lives annually and save some 1.04 trillion each year – some 20% of our health care spending. What’s not to like? I’m sure Bernie Sanders is already drafting the bill.

AI needs to give back, especially for health. Credit: Microsoft Designer
The
savings come from five sources: using Medicare payment rates for all providers,
using “international reference pricing” for pharmaceuticals, reducing
administrative costs to Medicare’s levels, reducing fraudulent billing (“consistent
with the experience of other single-payer transitions”), and reducing emergency
room visits and hospitalizations due to improved access to primary care. Good goals, all.
![]() |
| Credit: Pandey, et. al. |
Steffie Woolhandler
and David Himmelstein, among others, have been making these or similar
arguments for decades, and they are not without merit. It
is shameful that we don’t have universal coverage. It is distressing how much
money we spend on healthcare. It is embarrassing that we spend so much money on
administration. It is maddening that so
many people don’t get the care they need, get the wrong care, or get their care
in the wrong places/at the wrong times.
We could
do better, we should do better, but, if anything, we’re doing worse: more
people are losing coverage, more providers are
going out of business, our rates of chronic
(and some infectious
diseases) are going up, and we’re dying
sooner.
I want to
quickly point out some of the problems with the proposed sources of savings,
then discuss other courses of action that might lead to these or even better
outcomes.
- Medicare
payment rates:
yes, a lot of money could be saved by using Medicare payment rates, but I doubt
you would find many providers who would say they could survive. They make their
money on private insurance rates, are lucky to break even on Medicare rates,
and lose money on Medicaid. This one is not going to happen.
- International
pharmaceutical reference pricing:
first, I’m not sure such a thing exists. It is true that drug prices are
typically lower in other countries. Both President Biden and President Trump
seized upon this, with some signs of modest success. But, as with the Medicare
pricing, it would be a shock to the pharmaceutical industry to have prices
slashed across the board, wiping out trillions of dollars of value and,
oh-by-the-way, eventually reducing investments on new and better prescriptions.
- Administrative
costs: as a
percentage of spending, Medicare’s administrative costs are lower than private
insurance, but that is partly due to Medicare spending per capita being so much
higher. Also, costs incurred by other agencies – e.g., Social Security or the
IRS – are not always counted. But certainly the complexities of so many plan
designs by so many health insurers while tracking the current eligibility of
everyone is a cost that is much higher than it should be.
- Reducing
fraudulent billing:
I mean, really: do people really think that Medicare does a better job of
reducing fraudulent billing than United Healthcare or Anthem, much less than
other countries?
- More
primary care:
reducing emergency room visits and hospitalizations has been the goal of
countless private health insurance efforts, such as disease management or
chronic health programs, and the track record has generally been underwhelming.
But the real problem is – where are we going to get all the primary care
physicians to handle all the underserved people?
So, much
as I agree with the goals, count me a skeptic that single payor is going to
magically make everything better.
Here’s
where I inevitably turn to AI. An article by Alex Janin in The
Wall Street Journal
marveled at how “AI Is Helping Patients Solve Medical Mysteries.” Ms. Janin writes: “AI can be especially adept
at flagging potential rare and hard-to-diagnose diseases, which may otherwise
go undetected for years because doctors don’t often see them.”
That’s the
kind of use AI advocates have been promising for years, and it is exciting to
see this use finally bearing some fruit. For the small percent of patients with
these kinds of diseases, AI can literally be a lifesaver, but let’s remember
that they are a small percent. When I read the article, I keep thinking about
bigger problems I want AI focused on. E.g.,
·
Flagging
fraudulent and/or duplicative billing;
·
Identifying
both unnecessary tests and procedures and the providers who most commonly
perform them;
·
Identifying
providers who deliver sub-standard care.
Want a
more efficient/effective healthcare system? Let’s start there. The savings
potential may not be as gaudy as Yale’s $1.04t, but these would not require as
massive an upheaval.
While I’m
at it, I want to bring up another AI-related area of healthcare. The
not-so-hidden but too-little discussed secret of U.S. healthcare is that we
have a lot of third world outcomes, largely in lower socioeconomic households
and disproportionately impacting people of color.
Sure, we
can put in single payor, but will that solve the problem of rural Mississippi
or south side Chicago? Too many people don’t have access to clean air, clean
water, enough food, adequate shelter, or accessible/affordable healthcare. The
great lesson of 20th century U.S. healthcare was not the gains from
new medicines or more hospitals/physicians, but in public health efforts like
improved sanitation and more immunizations.
By every
measure of income inequality or social mobility, we’re in a have/have not
society, and there is every reason to believe AI will make that so, so much
worse. It’s going to be NAFTA but much worse. But I always remember: NAFTA
didn’t cause all those jobs to go abroad. Those jobs went because U.S. CEOs
chose to send them abroad, in order to make them and their stockholders richer.
Think they won’t do the same with AI?
That’s why
I firmly, fiercely believe we need some sort of AI
tax to help make the adjustment to the new AI world. The financial gains
from AI need to be broadly distributed, and one of those distributions has to
be for addressing our third world health outcomes. That could be through 21st
century public health investments, and/or through some sort of universal basic
income (UBI).
Universal coverage might be nice, but an AI tax for public health and universal basic income might be necessary.


No comments:
Post a Comment